| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,057 |
15,379 |
$1.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,892 |
12,653 |
$580K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,782 |
1,753 |
$139K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
720 |
711 |
$67K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
719 |
702 |
$61K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,926 |
1,898 |
$51K |
| 92015 |
Determination of refractive state |
3,720 |
3,635 |
$44K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
1,866 |
1,841 |
$44K |
| 90834 |
Psychotherapy, 45 minutes with patient |
416 |
266 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
7,669 |
6,972 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,222 |
1,172 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
630 |
612 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,608 |
2,498 |
$21K |
| V2020 |
Frames, purchases |
777 |
659 |
$19K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,951 |
2,892 |
$15K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
212 |
203 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
496 |
484 |
$12K |
| 0001A |
|
449 |
447 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
828 |
807 |
$10K |
| 92551 |
|
1,556 |
1,527 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
126 |
124 |
$10K |
| 0002A |
|
381 |
378 |
$9K |
| 99215 |
Prolong outpt/office vis |
80 |
79 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
316 |
308 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
302 |
294 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
493 |
456 |
$8K |
| 90686 |
|
1,256 |
1,230 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
786 |
778 |
$7K |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
344 |
168 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,045 |
994 |
$6K |
| 80061 |
Lipid panel |
389 |
383 |
$5K |
| 92341 |
|
136 |
132 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
258 |
252 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
98 |
95 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
542 |
517 |
$4K |
| 87081 |
|
1,251 |
1,202 |
$4K |
| 92134 |
|
126 |
124 |
$4K |
| 81001 |
|
1,295 |
1,233 |
$3K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
81 |
81 |
$3K |
| 99173 |
|
1,438 |
1,410 |
$2K |
| 80053 |
Comprehensive metabolic panel |
182 |
179 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
222 |
215 |
$2K |
| 99188 |
|
249 |
248 |
$1K |
| 80047 |
|
83 |
81 |
$654.44 |
| 87210 |
|
144 |
138 |
$601.20 |
| 96127 |
|
152 |
150 |
$548.30 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
14 |
$508.78 |
| 0134A |
|
14 |
14 |
$459.92 |
| 85027 |
|
87 |
80 |
$443.21 |
| 90651 |
|
46 |
41 |
$428.74 |
| 81025 |
|
74 |
70 |
$355.93 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
32 |
16 |
$345.76 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
25 |
$230.01 |
| 0064A |
|
14 |
12 |
$194.05 |
| 86803 |
|
13 |
13 |
$188.49 |
| G0008 |
Administration of influenza virus vaccine |
13 |
12 |
$155.79 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$132.68 |
| 90656 |
|
15 |
15 |
$38.56 |
| X5622 |
|
755 |
748 |
$0.00 |
| 91300 |
|
60 |
54 |
$0.00 |
| 90734 |
|
15 |
14 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$0.00 |